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Studies have shown that electroacupuncture (EA) ameliorates learning and memory after ischemic injury. However, there have
been few studies elucidating the mechanisms of EA on learning and memory in cerebral hypoperfusion. In this study, we explored
the cAMP response element-binding protein (CREB) signaling pathway-mediated antiapoptotic action involved in EA-induced
improvement of learning and memory. EA at GV20 and GV14 acupoints was applied in cerebral hypoperfusion rats. A Morris
water maze task was performed, and the immunoreactivities of pCREB, Bcl-2, and Bax in the hippocampal CA1 area were evaluated
by the Western blotting technique. Our findings indicated that (1) EA ameliorated spatial learning and memory impairment in
cerebral hypoperfusion rats; (2) EA increased the immunoreactivities of pCREB and Bcl-2 and decreased the immunoreactivity of
Bax; (3) intracerebroventricular administration of H89 (the inhibitor of protein kinase A) blocked EA-induced, pCREB-mediated
antiapoptotic action and improved learning and memory. These results suggest that EA can ameliorate learning and memory via
activation of the CREB signaling pathway in the hippocampus to attenuate apoptosis after cerebral hypoperfusion.
1. Introduction
Up to 64% of persons who have experienced a stroke have
some degree of cognitive impairment [1], with up to a third
developing frank dementia [2, 3]. Disorders of learning and
memory, which are among the most common cognitive
impairments, severely affect the curative efficacy and the
quality of survivors’ lives.
Some brain regions, such as the hippocampus, are more
vulnerable to ischemic damage [4]. CA1 hippocampal pyra-
midal neurons exhibit cell death several days after ischemic
injury [5]. Spatial memory in rats and humans is largely
dependent on the hippocampus [6]. Hippocampal neuronal
damage induced by ischemia, especially in the CA1 pyramidal
neurons, is associated with spatial learning and memory
impairment [7].
The cAMP response element-binding protein (CREB)
is necessary for proliferation, growth, survival, and dif-
ferentiation of all types of cells. In the brain, the CREB
and CRE-mediated system is related to memory, learning,
and synaptic transmission as well as in neuron survival.
In neurons, CREB influences the expression of a variety of
genes, of which brain-derived neurotrophic factor (BDNF)
[8], c-fos [9], and Bcl-2 [10, 11] have been studied intensely.
Because Bcl-2 is an antiapoptotic protein, CREB-mediated
Bcl-2 expression is believed to be protective against ischemic
insult [12]. Although CREB phosphorylation is increased in
the whole hippocampus [13, 14], CREB activity is decreased
in vulnerable CA1 neurons after ischemic insult [13]. Given
that CREB activation is neuroprotective, an approach to
induce CREB activation in vulnerable CA1 neurons might
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be a promising strategy to protect the brain against ischemic
insult and ameliorate learning and memory.
Electroacupuncture (EA) delivers electrical stimulation
to acupuncture points through acupuncture needles. EA
has been recommended as a complementary therapy in the
global scope of stroke rehabilitation. Several studies inves-
tigating the effectiveness of EA with cerebral ischemia have
been conducted, and beneficial neuroprotective effects have
been observed [15–18]. Both in animal models of cognitive
impairment and in patients with deficiencies of learning and
memory, some inspiring outcomes of EA have been reported
[19, 20]. However, there have been few studies elucidating the
mechanisms of EA on learning and memory in an animal
model of cerebral hypoperfusion. Therefore, we determined
whether EA could ameliorate learning and memory through
the activation of the CREB signaling pathway in the hip-
pocampus to attenuate apoptosis in a rat model of cerebral
hypoperfusion.
2. Materials and Methods
2.1. Animals. Forty male Sprague-Dawley rats (Huazhong
University of Science and Technology Experimental Animal
Center, Wuhan, China) were used for the study. All animal
experiments were approved by the ethics committee of the
Tongji Medical College. All rats, each weighing 220 ± 20 g
(age 7-8 weeks), were randomly divided into five groups (𝑛 =
8 in each group): a sham-operated control group (control
group), a model group, an EA group, an EA combined with
intracerebroventricular (ICV) injection of saline group (EA +
NS group), and an EA combined with ICV injection of H89
group (EA + H89 group).
2.2. Surgical Procedures. Cerebral hypoperfusion was in-
duced by permanent, bilateral common carotid artery occlu-
sion (2-vessel occlusion, 2VO) in all groups except the control
group. During the surgical procedures, rectal temperature
was maintained at 37 ± 0.5∘C with a heat lamp. The animals
were anesthetized with 400mg/kg chloral hydrate i.p. A
ventral cervical incision was made in the midline to expose
the common carotid arteries, which were gently separated
from their sheaths and vagal nerves, and permanently ligated
with surgical sutures. In the control group, the arteries were
similarly exposed, but not ligated.
2.3. ICV Injection Protocol. The rats were anesthetized with
chloral hydrate (400mg/kg, i.p.), and their heads were fixed
in a stereotaxic frame. H89 (2𝜇g/𝜇L × 10 𝜇L, Beyotime
Institute of Biotechnology, Shanghai, China.) was given
intracerebroventricularly in the right hemisphere, 5–10min
before 2VO, similar to a previous study [21]. The coordinates
for intracerebroventricular injectionswere as follows: 0.8mm
posterior to the bregma, 1.5mm lateral to the midline, and
4.0mm below the dural surface. The injection speed was
controlled by a syringe pump at a rate of 2𝜇L/min. The
needle was retained in place for 5min after injection. The
EA combined with ICV injection of NS group underwent
GV20
GV14
Figure 1: Rat schematic showing the location of the acupuncture
points used in the study. GV14 stands for “Da zhui,” which is located
on the posterior midline and in the depression below the spinous
process of the seventh cervical vertebra; GV20 stands for “Bai hui,”
which is located at the right midpoint of the parietal bone.
the same ICV injection protocol, but a corresponding volume
of saline was injected instead of H89.
2.4. Treatment Protocol. For EA treatment, “Bai hui” (GV20),
which is located at the right midpoint of the parietal bone,
and “Da zhui” (GV14), which is located on the posterior
midline and in the depression below the spinous process
of the seventh cervical vertebra (Figure 1), were located
as in our previous study [22]. GV20 and GV14 were then
electrically stimulated with a G6805-II electroacupuncture
therapeutic apparatus (Shanghai Medical Electronic Appara-
tus Company, China) with continuous current at 20Hz and
1-2mA intensity for 20 minutes, once a day. EA was delivered
to the rats from the day the 2VO model was established;
the intervention lasted for 7 days. The rats in the control
and model groups were fed in their cages without special
intervention.
2.5. Morris Water Maze Task. On the 5th day after 2VO
onset, the Morris water maze task was performed to test
spatial learning and memory as described previously [23].
The maze consisted of a black circular pool (diameter 2m,
height 80 cm, and filled with water at 21-22∘C to a height
of 50 cm). The platform (10 cm in diameter) was hidden
2 cm below the surface of the water made opaque with ink.
Several constant, large visual cues surrounded the tank at
a height of 120–150 cm to facilitate orientation. The starting
points were changed every day. Each trial lasted either until
the rat found the platform or for 60 s. The rats rested on
the platform for 20 s after each trial. The latency to find
the submerged platform and the swimming distance were
recorded.The speed of swimmingwas equal to the swimming
distance divided by the latency. Two sessions of the four trials
were conducted within a 4 h interval on the first testing day.
The first session was considered a training procedure. One
session out of the four trials was conducted daily during
the next 2 testing days. Four hours after the last trial, the
platform was removed for a 60 s spatial probe trial. The
frequency of swimming across the platform in the training
quadrant, that is, the previous location of the platformand the
swimming distance in 60 s, was recorded (Ethovision; Noldus
Information Technology, The Netherlands). The speed of
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swimming was equal to the swimming distance divided by
60 s.
2.6. Western Blotting Analysis. Total tissues of both sides
of the hippocampal CA1 area were obtained, dissected into
pieces, and extracted with the Total Protein Extraction Kit
(ProMab, Richmond, CA, USA). A sample of each fraction
was treated at 95∘C for 10min in SDS solubilization buffer
and then separated on a 10% SDS-polyacrylamide gel (SDS-
PAGE). The proteins were then transferred to nitrocellulose
membranes (PIERCE, Rockford, IL, USA). Immunoblotting
was performed using primary antibodies to pCREB (1 : 400,
Santa Cruz, Inc., CA, USA), Bcl-2 (1 : 500, CST, Boston, MA,
USA), and bax (1 : 1000, CST) for 2 h at room temperature
and then incubated at 4∘C overnight. After washing with PBS
containing 0.05% Tween-20, the membranes were incubated
with horseradish peroxidase-conjugated secondary antibod-
ies (1 : 5000, Santa Cruz) for 1 h at room temperature. Protein
bands were detected using an enhanced chemiluminescence
method (ECL kit, Santa Cruz) according to the manufac-
turer’s instructions.The optical densities of the specific bands
of pCREB, Bcl-2, and bax were normalized based on the
GAPDH band (1 : 500, Santa Cruz). Quantitation of bands
was undertaken using Gel-Pro analyzer 4.0 software (Media
Cybernetics, USA).
2.7. Statistical Analysis. The experimental results for each
group are expressed as the mean ± SEM. A 𝑡-test (for the
EA + NS and EA + H89 groups) and ANOVA with Student-
Newman-Keuls post hoc analysis (for the control, model
and EA groups) were performed. Statistically significant
differences were set at 𝑃 < 0.05.
3. Results
3.1. Morris Water Maze Task. The rats were trained on the
Morris water maze from the 5th day until the 7th day,
followed by the place navigation trial and spatial probe trial.
The latency to find the submerged platform, the swimming
time across the platform, and the swimming distance were
recorded by the samepersonwhowas blind to the grouping of
the rats. In the place navigation trial, there were no significant
differences in the swimming speed either among the control,
model, and EA groups or between the EA + NS and EA +
H89 groups (Figures 2(c)-2(d)), which was similar to in the
spatial probe trial (Figures 3(c)-3(d)). The result indicated
that the effect of 2VO was on learning and memory and not
on motor performance. In the place navigation trial, cerebral
hypoperfusion had an effect on water maze acquisition as
demonstrated by the prolonged latency (41.40 ± 13.96 s) to
locate a hidden platform in the model group rats compared
with the control group (12.28 ± 4.53 s, 𝑃 < 0.01). In the EA
group (18.48 ± 5.74 s), the latency was shorter than that of
the model group (𝑃 < 0.05; Figure 2(a)). After ICV injec-
tion of H89, rats demonstrated prolonged latency (36.95 ±
11.94 s) compared with the EA+NS group (22.67 ± 5.53 s, 𝑃 <
0.05; Figure 2(b)). In the spatial probe trial, the frequency of
swimming across the platform in 60 s in the model group
(1.50 ± 0.53) decreased compared with that of the control
group (3.38 ± 0.93, 𝑃 < 0.05). In the EA group (2.63 ± 0.53),
the frequency increased compared with that of the model
group (𝑃 < 0.05; Figure 3(a)). However, in the EA + H89
group (1.75 ± 0.73), the frequency decreased compared with
that of the EA+NS group (2.88± 0.64,𝑃 < 0.05; Figure 3(b)).
3.2. Effects of EA on the Immunoreactivity of pCREB. The
effects of EA on the immunoreactivity of pCREB in the
hippocampal CA1 area were examined by Western blotting
analysis (Figure 4). A significant decrease in the immunore-
activity of pCREBwas observed in the hippocampal CA1 area
after 2VO. Treatment with EA significantly attenuated the
decrease in the immunoreactivity of pCREB (Figure 4(a)).
Likewise, the immunoreactivity of pCREB increased in the
EA + NS group, but this increase was markedly inhibited by
ICV injection of H89 (Figure 4(b)).
3.3. Effects of EA on the Immunoreactivities of Bcl-2 and Bax.
One of themainmechanisms involved in the induction of the
apoptotic pathway is the decrease in Bcl-2 levels or, alterna-
tively, an increase in Bax levels. The Bcl-2 family is involved
in cell death processes and plays a pivotal role in the cellular
apoptotic machinery [24]. Bcl-2 is an antiapoptotic protein,
and Bax exhibits proapoptotic activity [24, 25]. To investigate
whether EA could attenuate apoptosis in the hippocampus
after cerebral hypoperfusion, the immunoreactivities of Bcl-2
and Bax in the hippocampal CA1 area were examined
by Western blotting analysis. Cerebral hypoperfusion had
an effect on apoptosis in the hippocampal CA1 area as
demonstrated by the decreased immunoreactivity of Bcl-2
and increased immunoreactivity of Bax in the model group
rats compared with that of the control group. In the EA
group, the immunoreactivity of Bcl-2 significantly increased
and the immunoreactivity of Bax significantly decreased
compared with that of the model group (Figures 5(a) and
5(c)). However, in EA + H89 group, the immunoreactivity
of Bcl-2 significantly decreased and the immunoreactivity of
Bax significantly increased compared with that of the EA +
NS group (Figures 5(b) and 5(d)).
4. Discussion
In the present study, we provide evidence that EA ameliorates
learning and memory through the activation of the CREB
signaling pathway in the hippocampal CA1 area to attenuate
apoptosis after cerebral hypoperfusion. The ultimate goal of
acupuncture is to restore internal balance and harmony. As
one form of acupuncture, EA delivers electrical stimulation
to the acupoints through needles. A considerable number
of investigations have been conducted studying the effec-
tiveness of EA in treating cerebral ischemia. Several ben-
eficial outcomes have been observed, including protection
of neurological function by decreasing the infarct volume
and activation of the retinoic acid signaling pathway [26],
improved cerebral blood flow and attenuation of moderate
ischemic injury via an endothelial mechanism [27], and
activation of the cerebral structures related tomotor function



























































































Figure 2: The traces of swimming in place navigation trials, the latency time to find the submerged platform, and the swimming speed of
the five groups. The grey lines are the swimming traces, which end at the platforms (the small red circles in quadrant III). EA decreased the
latency time of rats with cerebral hypoperfusion (a), and after ICV injection of H89, rats demonstrated prolonged latency (b), while there
were no significant differences in the swimming speed either among the control, model, and EA groups or between the EA + NS and EA +
H89 groups ((c) and (d)). The data are expressed as the mean ± SEM. ANOVA statistical analyses were performed to compare the means
among the control, model, and EA groups; △𝑃 < 0.01 compared with the control group; 󳵳𝑃 < 0.05 compared with the model group. A 𝑡-test
was used to compare the means between the EA + NS and EA + H89 groups; ∗𝑃 < 0.05 compared with the EA + NS group.
















































































































EA + NS EA + H89
Figure 3: The traces of the 60 s spatial probe trials, the frequency of swimming across the platform site, and the swimming speed of the five
groups. Cerebral hypoperfusion effected the spatial probe trial as demonstrated by the decreased frequency of swimming across the platform
during the 60 s interval. In the EA group, the frequency increased (a); after ICV injection of H89, the increased frequency decreased (b),
while there were no significant differences in the swimming speed either among the control, model, and EA groups or between the EA + NS
and EA + H89 groups ((c) and (d)). The data are expressed as the mean ± SEM. ANOVA statistical analyses were performed to compare the
means among the control, model, and EA groups; n𝑃 < 0.05 compared with the control group; 󳵳𝑃 < 0.05 compared with the model group.
A 𝑡-test was used to compare the means between the EA + NS and EA + H89 groups; ∗𝑃 < 0.05 compared with the EA + NS group.
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Figure 4: Western blotting showing immunoreactivity of phosphorylated CREB in the hippocampal CA1 area. The pCREB protein values
were calculated as a ratio of pCREB protein to GAPDH. EA increased the expression of pCREB protein (a), and the EA-induced activation
of pCREB was markedly inhibited by ICV injection of H89 (b). The data are expressed as the mean ± SEM. ANOVA statistical analyses were
performed to compare themeans among the control, model, and EA groups; n𝑃 < 0.05 comparedwith the control group; 󳵳𝑃 < 0.05 compared
with the model group. A 𝑡-test was used to compare the means between the EA + NS and EA + H89 groups; ∗𝑃 < 0.05 compared with the
EA + NS group.
on the bilateral hemispheres [16]. In the present study, the
model group showed prolonged latency to locate a hidden
platform and decreased frequency of swimming across the
platform during a 60 s period compared with the control
group. After EA treatment, the latency was shortened and the
frequency increased in the EA group. These results suggest
that EA could ameliorate learning and memory after cerebral
ischemia, consistent with previous reports [18, 28].
EA is a proven, effective therapy for ameliorating learning
and memory, but the underlying mechanisms remain uncer-
tain. In this study, we investigated the immunoreactivity of
pCREB and apoptotic status in the hippocampal CA1 area.
Though there were some measurements of apoptosis (i.e.,
TUNEL labeling, activated Caspase 3, etc.) to document
an apoptotic mechanism, we explored the CREB signaling
pathway-mediated antiapoptotic action in our study. The
expression of Bcl-2 is mediated by CREB [10–12], and
pCREB plays a role in the decrease of Bax expression [29].
Moreover, Bcl-2 is an antiapoptotic protein and Bax exhibits
proapoptotic activity. So, a special emphasis was put on Bcl-2
and Bax to investigate the apoptotic status in our study.
The model group showed decreased immunoreactivity of
pCREB in the hippocampal CA1 area after 2VO, consistent
with Walton’s report [13], decreased immunoreactivity of
Bcl-2, and increased immunoreactivity of Bax. After treat-
ment, increased immunoreactivity of pCREB and Bcl-2 and
decreased immunoreactivity of Bax were observed in the
EA group. These results suggest that EA is involved in
proapoptotic activity, which may be mediated via activation
of CREB phosphorylation.
Furthermore, the importance of activating the CREB
pathway after EA was demonstrated by ICV injection of H89.
Nuclear CREB is phosphorylated and activated by cAMP-
dependent protein kinase (PKA) and, consequently, binds
to the cAMP response element (CRE) of target genes [30].
As the inhibitor of protein kinase A, H89 can inhibit CREB
phosphorylation [10]. To control against nonspecific effects,
a control ICV injection of NS was used. In the present study,
ICV injection of H89 inhibited the improvement of spatial
learning and memory after EA treatment. Moreover, ICV
injection of H89 significantly inhibited CREB phosphory-
lation, reduced the expression of antiapoptotic Bcl-2, and
significantly increased the expression of proapoptotic Bax.
These results suggest that EA treatment could improve learn-
ing and memory after cerebral hypoperfusion via the CREB-
mediated signaling pathway and subsequent activation of
target proteins, such as the antiapoptotic protein Bcl-2, to
attenuate apoptosis.

































































Figure 5: Western blotting showing immunoreactivity of apoptosis-related proteins in the hippocampal CA1 area.The Bcl-2 and Bax protein
values were calculated as a ratio of Bcl-2 and Bax protein to GAPDH. EA increased the expression of Bcl-2 and decreased the expression
of Bax ((a) and (c)). However, the antiapoptotic action of EA was markedly inhibited by ICV injection of H89 ((b) and (d)). The data are
expressed as the mean ± SEM. ANOVA statistical analyses were performed to compare the means among the control, model, and EA groups;
△
𝑃 < 0.01 compared with the control group; 󳵳𝑃 < 0.05 compared with the model group. A 𝑡-test was used to compare the means between
the EA + NS and EA + H89 groups; ∗𝑃 < 0.05 compared with the EA + NS group.
5. Conclusions
In conclusion, the present study demonstrated that EA can
improve cognitive impairment after cerebral hypoperfusion.
The protective effect of EA was associated with its antiapop-
totic mechanism through the pCREB-mediated signaling
pathway. These results indicate that EA could be a promising
candidate for complementary therapy to ameliorate learning
and memory after cerebral ischemia.
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